Age-related morphologic development of human adrenal zona reticularis (ZR) has not been well examined. Therefore, in this study, 44 human young adrenal autopsy specimens retrieved from large archival files (nZ252) were examined for immunohistochemical and morphometric analyses. Results demonstrated that ZR became discernible around 4 years of age, and both thickness and ratio per total cortex of ZR increased in an age-dependent fashion thereafter, although there was no significant increment in total thickness of developing adrenal cortex. We further evaluated immunoreactivity of both KI67 and BCL2 in order to clarify the equilibrium between cell proliferation and apoptosis in the homeostasis of developing human adrenals. Results demonstrated that proliferative adrenocortical cells were predominantly detected in the zona glomerulosa and partly in outer zona fasciculata (ZF) before 4 years of age and in ZR after 4 years of age, but the number of these cells markedly decreased around 20 years of age. The number of BCL2-positive cells increased in ZR and decreased in ZF during development. Adrenal androgen synthesizing type 5 17b-hydroxysteroid dehydrogenase (HSD17B5 or AKR1C3 as listed in the Hugo Database) was almost confined to ZR of human adrenals throughout development. HSD17B5 immunoreactivity in ZR became discernible and increased from around 9 years of age. Results of our present study support the theory of age-dependent adrenocortical cell migration and also indicated that ZR development is not only associated with adrenarche, but may play important roles in an initiation of puberty.
Introduction
Human adrenarche is generally characterized by the appearance of axillary hair, pubarche, and a transient acceleration of linear growth and bone maturation. Adrenarche has also been defined as the increased production of dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) in human adrenal cortex, which occurs between 6 and 8 years of age (Parker & Odell 1980 , Voutilainen et al. 1983 . The onset and characteristics of adrenarche are also well known to be associated with alterations in both adrenocortical functions and morphology (Parker et al. 1983 , Gell et al. 1996 . The zona reticularis (ZR) is generally considered the site for DHEA and DHEAS synthesis , Hyatt et al. 1983 , Endoh et al. 1996 , Rainey & Nakamura 2008 . Therefore, an increment of adrenal androgen production has been considered to be closely associated with temporal and spatial morphologic changes in the ZR during adrenarche (Dhom 1973 , Parker et al. 1983 , Rainey et al. 2002 .
Functionally, the ZR-specific or preferential steroid metabolizing enzymes have been proposed to play important roles in the biosynthesis of DHEA and DHEAS . Dhom was the first to carefully examine the appearance and continuous development of ZR and suggested the possible correlation between adrenal androgen productions and morphologic development of the ZR in human adrenal glands (Dhom 1973) . Results of other published histomorphologic studies demonstrated a reduction in histologically identifiable ZR width, which is proportional to the width of cytochrome b5 immunopositive cortical cells. (Dharia et al. 2005) ; however, the total cortical width remained the same throughout the ages, suggesting that ZR regression in elderly population may account for the diminished production of DHEAS, a phenomenon also termed 'adrenopause' (Parker et al. 1997) . In our present study, we used immunohistochemical analysis for adrenocortical steroidogenic enzymes in order to fully characterize the morphometric and functional changes of human adrenocortical ZR in both males and females from infancy to adolescence.
Adrenal tissue represents a cell renewal system in which the adaptive structural remodeling is accomplished by a balance between cell proliferation and apoptosis (Leblond 1964) . However, the cellular dynamics underlying postnatal development of the ZR during adrenarche has remained unknown. Therefore, we further evaluated alterations of immunoreactivity of KI67 (listed as MKI67 in the Hugo Database) and BCL2 in human young adrenal cortex during ZR development in order to obtain a better understanding of cytogenesis of ZR.
The correlation of adrenarche with the initiation of puberty has also not been well evaluated. In particular, the morphologic correlation between adrenarche and puberty has remained still unknown. Therefore, we evaluated 17b-hydroxysteroid dehydrogenase (HSD17B5) during ZR development with attempt to study the relationship between alterations within the adrenal during adrenarche and the age of puberty. Results of a recent study have demonstrated that HSD17B5, which plays an important role in the conversion of sex steroids, is also expressed in human adrenal gland (Petry et al. 2007 ). HSD17B3 provides w50% of the total amount of testosterone in men by synthesizing testosterone from androstenedione (Geissler et al. 1994 , Labrie et al. 2005 , but the same enzymatic reaction is catalyzed in peripheral target tissues via HSD17B5 and HSD17B1, not through HSD17B3. HSD17B5 has been reported to be most abundantly expressed in the human adrenal compared to HSD17B1 and HSD17B3 (Dufort et al. 1999 , Qin & Rosenfield 2000 , Nakamura et al. 2009 ). In addition, HSD17B5 has also recently been reported to be expressed at higher levels in human ZR using quantitative PCR and immunohistochemistry (Nakamura et al. 2009 ). Therefore, in this study, we included the chronological analysis of HSD17B5 expression during ZR development in human adrenals using immunohistochemistry.
Materials and Methods

Tissues and age groups
Human adrenal autopsy specimens from birth to adolescence (nZ252, from postnatal 7 months to 20 years of age) were retrieved from autopsy files of Tohoku University Hospital and National Hospital Organization, Sendai Medical Center from 1990 to 2007 (Sendai, Japan). Forty-four specimens were selected for this study from the large group of archival tissue specimens following careful histological or morphological screening from the standpoints of the following four criteria: tissue collection in !3 h postmortem; no histories of administration of adrenocortical steroids or chronic illness prior to death; no pathological abnormalities including adrenocortical nodules or neoplasms; full thickness of the adrenal extending from capsule to medulla available in the specimens. After gender stratification, the specimens were tentatively assigned into three age groups: group 0-3 years of age (nZ5 in male; nZ4 in female); group 4-12 years of age (nZ8 in male; nZ5 in female); group 13-20 years of age (nZ12 in male; nZ10 in female). From these paraffinembedded specimens, 3 mm thickness tissue sections were prepared for immunostaining. This protocol was approved by Institutional Review Board of Tohoku University School of Medicine (2004-355) and National Hospital Organization, Sendai Medical Center.
Antibodies
The polyclonal antibodies for steroid sulfotransferase type 2A1 (SULT2A1) (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-18725), HSD3B2 (1:2500, rabbit antiplacental HSD3B2) employed in this study, have been previously described. Briefly, the antibody directed against HSD3B2 has been characterized as specific for immunohistochemical and western analyses (Doody et al. 1990 , Lorence et al. 1990 , Sasano et al. 1990 ). The antibody SULT2A1 was a goat polyclonal IgG preparation against a peptide mapping within an internal region of SULT2A1 of human origin, and has been demonstrated to be specifically expressed in human liver and adrenal tissues using both western blot and immunohistochemical evaluations (Otterness et al. 1992 , Comer et al. 1993 , Forbes et al. 1995 . In addition, the monoclonal antibodies KI67 (MIB-1, 1:100 DAKO, Glostrup, Denmark) and BCL2 (1:80 DAKO) were also used in this study. A monoclonal anti-human HSD17B5 antibody (also called AKR1C3, 1:200 Sigma) was obtained from Sigma-Aldrich. This antibody was previously reported not to cross react with human AKR1C1, AKR1C2, or AKR1C4 (Lin et al. 2004) .
Immunohistochemistry
Immunohistochemical analyses were performed by the streptavidin-biotin amplification method using a Histofine kit (Nichirei, Tokyo, Japan). Briefly, after deparaffinization, tissue sections were treated with 0 . 3% hydrogen peroxidase in methanol for 30 min at room temperature to quench endogenous peroxidase activity and then treated with 1% normal rabbit or goat (when the primary antibody was developed in rabbit) serum for 30 min at room temperature in a moisture chamber. The sections for KI67 and BCL2 immunostaining were immersed in citric acid buffer (0 . 002 M citric acid and 0 . 009 M trisodium citrate dihydrate, pH 6 . 0) and heated in autoclave for 5 min at 127 8C and were then allowed to cool for w1 h at room temperature for antigen retrieval. The diluted primary antibodies were incubated with sections for at least 18 h at 4 8C. After rinsing in 0 . 01 M PBS, sections were incubated with the biotinylated second antibodies for 30 min at room temperature, followed by exposure to peroxidase-conjugated streptavidin for 30 min at room temperature. The antigenantibody complexes were subsequently visualized by immersion in 3,3 0 -diaminobenzidine (DAB) solution (0 . 001 M DAB, 0 . 05 M Tris-HCl buffer, pH 7 . 6, 0 . 01 M sodium azide, and 0 . 006% hydrogen peroxidase).
Hematoxylin was used as a nuclear counterstain. We performed immunohistochemical evaluation in paraffinembedded human tissues, which are considered to serve as positive controls in order to further validate the characteristics of the antibodies employed. Briefly, human liver tissue was used for antibody SULT2A1 (Narasaka et al. 2000) , Cushing's adrenocortical adenoma tissue was used for HSD3B2 (Magrini et al. 1969 , Yanase et al. 1998 , and tonsil was used for both KI67 and BCL2 (Martinez-Valdez et al. 1996) . As negative controls of immunostaining, the primary antibodies were omitted and replaced with nonimmune serum and then the immunostaining procedure was completed as outlined above.
There was no immunostaining evident in such sections.
The immunostaining procedures were all performed as carefully as possible using the same conditions for all the tissue sections.
Quantitative measurement of adrenal cortex
Quantitative analysis of adrenal sections was performed using the microscope-attached computerized image capture and analysis system (Penguin/Pro 600ES Pixel Digital Camera System, USA). First, a standard micrograph was prepared as a measurement scale with a minimum unit of 10 mm using a 4! microscope objective. Micrograph of sections processed for SULT2A1 and HSD3B2 immunohistochemistry was then captured under the same conditions as the scale. Digital images of each adrenal section designating five separate quadrangle-shaped areas that contained full-thickness cross section of the cortex were prepared. Image-editing software (Adobe Photoshop Elements 5.0) was then used to adjust this captured micrograph. A straight line was drawn from the subcapsular area of the adrenal to the edge of medulla inward in the direction of cord-like zona fasciculata (ZF), followed by drawing another parallel line representative of the thickness of ZR. After these two straight lines were copied to the scale micrograph respectively, their lengths were expressed accurately in micrometers. Finally, five values were measured for each section and the average value was determined for the final analysis. To avoid any bias, all measurements were conducted in the blind fashion or without the knowledge of the age and sex of the donors. The data for analysis included the total cortical thickness, the thickness of ZR, and the ratio of the thickness of ZR to that of the total cortex expressed by % (R).
In addition, it is difficult or subjective to identify the ZR using hematoxylin and eosin staining only; therefore, we performed immunohistochemistry for SULT2A1, the enzyme responsible for the sulfonation of adrenally derived DHEA that is nearly exclusively localized in the ZR of human adrenal cortex . Results of previous studies demonstrated that cytochrome b5 could be served as ZR-specific marker by immunohistochemistry in the adrenal cortex of the mature rhesus macaque (Mapes et al. 1999) and human (Yanase et al. 1998 ), but it is also true that SULT2A1 was predominantly expressed in the cytoplasm of adrenocortical cells in the ZR . In addition, similar patterns of age-related alterations of immunoreactivity between cytochrome b5 and SULT2A1 in the ZR of the human adrenal cortex have been demonstrated . In our present study, in order to clarify the border between ZF and ZR, we additionally used immunohistochemistry for HSD3B2 for tissue sections obtained from subjects older than 8 years of age when the immunoreactivity of HSD3B2 was reported to be significantly weaker in the ZR than in the ZF (Gell et al. 1998 . In addition, Dardis et al. (1999) reported a decrement of mRNA levels of HSD3B2 in adrenals from children 8 years of age and older compared to children younger than 8 years of age. The combined use of immunohistochemistry for both SULT2A1 and HSD3B2 allowed exact localization and measurement of ZR for the specimens obtained from the subjects older than 8 years of age. Because the ZR in the sections between 4 and 8 years of age was demonstrated to be clearly identified by SULT2A1 solely, no immunohistochemistry for HSD3B2 was supplemented in such sections. Figure 1 Quantitative analyses of age-related morphologic changes in human adrenal cortex. Adrenal cortex was studied in 25 male and 19 female adrenal glands from 0 to 20 years of age. Tissues were processed as described in Materials and Methods, and slides were photographed at 4! microscope objective. (A) Total thickness in three age categories in both male and female adrenals (* versus 0-3 year olds in male, P!0 . 05; # versus 0-3 year olds in female, P!0 . 01); (B) ZR thickness in both male and female adrenals displayed more significant development of ZR in 13-20 year olds than that in the 4-12-year-old group (* versus 4-12 year olds in male, P!0 . 01; # versus 4-12 year olds in female, P!0 . 01); (C) the ratio of ZR thickness to that of total cortex in both male and female adrenals showed the significant difference between 13-20 and 4-12 year olds (* versus 4-12 year olds in male, P!0 . 01; # versus 4-12 year olds in female, P!0 . 01). Black bar, male; gray bar, female.
Evaluation of immunoreactivity
In our present study, three different methods were used to assess immunoreactivity. The immunoreactivity of KI67 was evaluated quantitatively by labeling index (LI), which represented the number of positive cells per 1000 adrenocortical cells. In detail, before counting, the areas for the analysis were determined by two of the authors (Suzuki & Akahira ) using a double-headed light microscope. For each section, five to 10 high-power fields (400!) were selected, and at least 1000 cells were independently counted by the two of the authors above. The tissue sections with interobserver differences of O5% were revaluated. We calculated the mean values only in the specimens with interobserver differences of !5%. The other evaluations were performed by two of the authors (Akahira & Hui). With respect to BCL2, a semiquantitative evaluation was used. For each adrenal section, the most immunointensitive region (76-100%) was given an arbitrary ranking of five and the medulla, which was negative, was designated 0 (%1%), and a scoring of 1-4 corresponded to 1-10, 11-30, 31-50, and 51-75% respectively. Histological identification of the three zones of the adrenal cortex was based on that of previous reports (McNicol 1992) . The immunoreactivity for each zone was subsequently determined by blind ranking of each slide by the authors above, and numerical values from each observer were then averaged. The quantitative evaluation of HSD17B5 was achieved by measuring the thickness of HSD17B5 immunoreactive ZR using the same measurement described above. The identical areas for both the measurements were designated in advance.
The correlation between the thickness of HSD17B5 immunoreactive ZR and that of morphologically determined ZR above was estimated by regression analysis.
Statistical analysis
All data were expressed as meanGS.D. Statistical analyses were appropriately performed by unpaired Student's t-test or oneway ANOVA or Wilcoxon's test followed by Bonferroni test for comparison between two groups according to the data types. P!0 . 05 was considered significant. Spearman correlation analysis (r) was used to evaluate association between two variations. All the above analyses were performed by use of SPSS software (SPSS 11.0, Chicago, IL, USA).
Results
Adrenal cortex total thickness
In the male adrenal cortex, the total thickness (mm) in the 0-3-year-old group (512 . 00G49 . 19) was significantly lesser than that in older groups examined in this study (P!0 . 01),
whereas there was no significant difference between older groups 4-12 years of age (846 . 75G222 . 43) and 13-20 years of age (956G185 . 21). In the female adrenal cortex, no significant difference was detected between the 0-3-year-old (669 . 25G160 . 46) and 4-12-year-old groups (865 . 20 G221 . 48). However, the size of the cortex in adrenals from the 13-20-year-old group (1063 . 60G155 . 74) was significantly larger than the 0-3-year-old group (P!0 . 01) but not in the 4-12-year-old group (Fig. 1A) . In male adrenals, the total thickness demonstrated a marked increment from 4 years of age until around 12 years of age but reached a plateau in the 13-20-year-old group. In female adrenals, the total thickness increased from the 0-3-year-old group and reached a plateau around 16 or 17 years of age.
The thickness of the ZR
The morphologically continuous ZR was not discernible in adrenals younger than 3 years of age. Therefore, the thickness of the ZR in the 0-3-year-old group was recorded as zero in both the male and female adrenals. Starting from around 4 years of age, the innermost ZR became morphologically discernible and demonstrated a progressive increment with age. The thickness of the ZR in the 13-20-year-old group was significantly greater than that in the 4-12-year-old group in both male and female adrenals (P!0 . 01). In detail, the thickness (mm) in the 4-12-year-old group was 185 . 25 Figure 2 Immunohistochemistry for KI67 and BCL2 in human adrenals. Adrenal expression of KI67 and BCL2 was studied in 44 adrenal glands from 0 to 20 years of age respectively. As shown in these representative micrographs, immunoreactivity of KI67 was almost detected in the ZG at 7 months of age (A), and strong immunoreactivity of KI67 was mostly detected in the ZR besides slight distribution in the transitional area between the ZF and the ZR around 15 years of age. (B) Immunoreactivity of BCL2 was easily detected in the outer ZF at 3 years of age (C), and strong immunoreactivity was detected in the ZR besides the weak immunoreactivity in outer ZF at 16 years of age. (D) Immunohistochemical detection of KI67 and BCL2 in human tonsil paraffin-embedded sections as positive controls were illustrated in micrograph E and G respectively, with corresponding negative controls in micrograph F and H respectively. The negative controls of human adrenal glands for immunohistochemistry of KI67 and BCL2 were also illustrated in micrograph I and J respectively. Bar represents 100 mm (A, B and E-I); bar represents 200 mm (C, D, and J). ZG, zona glomerulosa; ZF, zona fasciculata; ZR, zona reticularis; M, medulla. Full colour version of this figure available via http://dx.doi.org/10.1677/JOE-09-0127. (Fig. 1B) .
The ratio of the thickness of ZR to that of the total cortex (R)
In male adrenals, the R value (ZR % of total cortical thickness) was 21 . 34G4 . 49 in the 4-12-year-old group and was 35 . 86G7 . 12 in the 13-20-year-old group, which showed the significant difference (P!0 . 01). The difference was also significant between the 4-12-year-old group (27 . 81G4 . 14) and the 13-20-year-old group (37 . 83G7 . 8) in female adrenals (P!0 . 01; Fig. 1C ).
Comparison between male and female adrenals
There were no significant sex differences in the total adrenal thickness among any of the three age groups studied (PO0 . 05). In addition, adrenals from neither the 4-12-year-old group nor the 13-20-year-old group demonstrated a significant sex difference in the thickness of the ZR and the R values (PO0 . 05).
Immunohistochemistry for KI67
KI67-MIB1 (Goldblum et al. 1993 , Sasano et al. 1995 immunoreactivity was detected only in the nuclei of adrenocortical cells but not in those of capsule and medulla. In male adrenals, the immunoreactivity in the 0-3-year-old group was focally present in zona glomerulosa (ZG) with the highest LI (%) of 6 . 6 at 8 months of age and the average LI was 5 . 22G1 . 19; KI67-positive cells appeared in the ZR at 4 years of age and its number reached a peak at 12 years of age with the LI of 13 . 0. The average KI67-LI in the 4-12-year-old group was 5 . 63G3 . 40; KI67 immunoreactivity in ZR progressively declined around 20 years of age with the average KI67-LI of 2 . 64G1 . 50 in the 13-20-year-old group. Regardless of its intra-adrenal location of immunoreactivity, KI67-LI was higher in the 4-12-year-old group than that seen in the 13-20-year-old group (P!0 . 05). In female adrenals, immunoreactivity in specimens younger than 4 years of age was also mainly located in the ZG or sometimes in the outer ZF with the LI (%) of 7 . 05G3 . 10 in the 0-3-year-old group and the highest LI of 10 . 2 was detected at 7 months of age. However, the KI67-positive adrenocortical cells were also present in ZF before becoming discernible in ZR around 4 or 5 years of age and then increased later. The highest KI67-LI of 11 . 5 was detected predominantly in the inner ZR and partly in ZF at 15 years of age followed by progressive decrement toward 20 years of age (LI in the 4-12-year-old group was 2 . 50G1 . 44; LI in the 13-20-year-old group was 4 . 28G3 . 62). The representative images of distribution of KI67 immunoreactivity were summarized ( Fig. 2A and B) . The levels of KI67-LI in these three age groups are summarized in Table 1 .
Immunohistochemistry for BCL2
Previous studies reported the expression of BCL2 in normal human adrenal cortex (Fogt et al. 1998 , Bernini et al. 2002 . In our present study, BCL2 immunoreactivity was also demonstrated in the cytoplasm of adrenocortical cells but not in medulla or capsule. The age-related changes of BCL2 immunoreactivity were summarized in Table 2 . Briefly, before 4 years of age, relatively lower expression of BCL2 was detected in the adrenal specimens (it was recorded as 0 due to the absence of ZR). After 4 years of age, BCL2-positive cells frequently appeared in the ZF, especially in the outer part of this zone. In addition, BCL2 immunoreactivity in the ZF, mainly in the inner ZF adjacent to the ZR, decreased while it increased in the ZR with ages ( Fig. 2C and D) . Its immunoreactivity was significantly higher in the ZF than in the ZR in the 4-12-year-old group but higher in the ZR than in the ZF in the 13-20-year-old group (Fig. 3A and B) . The inversed correlation of immunoreactivity between the ZF and the ZR was also demonstrated in both male and female adrenals (rZK0 . 827, P!0 . 01 in male; rZK0 . 595, P!0 . 05 in female; Fig. 3C and D) . Figure 4 Immunoreactivity of HSD17B5 in young human adrenals. As shown in the representative micrograph, the immunoreactivity of HSD17B5 was not detected in the cytoplasm of adrenocortical cells in the ZR until around 9 years of age (A), followed by increased expression in the ZR at 19 years of age (B).
Positive control for immunohistochemistry was demonstrated in human liver paraffin-embedded section (C, see arrowhead); negative controls were illustrated in human liver and adrenal gland specimens respectively (D and E). Bar represents 200 mm (A, B, and E); bar represents 100 mm (C and D). ZG, zona glomerulosa; ZF, zona fasciculata; ZR, zona reticularis; M, medulla. Full colour version of this figure available via http://dx.doi.org/10.1677/JOE-09-0127.
Immunohistochemistry for HSD17B5
HSD17B5 immunoreactivity was detected in the cytoplasm of the ZR but not in the medulla or other cortical zones. In both male and female adrenals, HSD17B5 immunoreactivity in ZR was not easily discernible until w9 years of age, followed by increment with age up to 20 years of age ( Fig. 4A  and B) . The regression analysis demonstrated a significant positive correlation between the morphologically determined thickness of the ZR and that of HSD17B5 immunoreactive ZR (rZ0 . 991, P!0 . 01 in male; rZ0 . 989, P!0 . 01 in female; Fig. 5A and B) .
Discussion
Adrenal DHEAS secretion, in general, demonstrates a unique age-dependent pattern during the human life span. Before birth, DHEAS rises progressively to reach a peak at term followed by precipitous decline during the first months of life and remains low until adrenarche commences at w6-8 years of age . Serum DHEAS levels continue to rise and reach a peak during the second decade of life (Orentreich et al. 1984) . The production of DHEAS is so enormous during certain periods of our life span that DHEAS is indeed quantitatively the most abundant steroid hormone secreted by human adrenal. In addition, the ZR thickness has, in general, been postulated to correspond to increased production of DHEA and DHEAS (Dhom 1973 , Reiter et al. 1977 . It is, however, nearly impossible to correlate an increment in individual DHEAS levels during adrenarche with corresponding morphology of the ZR even employing sophisticated image analyses, and the functional development of the ZR has not been reported. Therefore, in our present study, we quantitatively and chronologically examined ZR development in young human adrenals using autopsy materials. Results of our quantitative study demonstrated the followings: 1) the total thickness of the adrenal cortex was significantly greater in older age groups, possibly due to the near absence of the adrenal ZR in younger children; 2) after 4 years of age, the expansion of the ZR started but did not result in a significant increment in the total thickness of the cortex, suggesting that the early stages of adrenarche relate to intra-adrenal remodeling (Figs 6 and 7) . Classically, human adrenarche was postulated to start between 6 and 8 years of age. Dhom (1973) reported that a continuous ZR development started to be seen around 6 years of age, which is different from 4 years of age, suggested in our study. However, results of our study are similar to more recent studies suggesting the morphologic onset of ZR probably occurs around 4 years of age (Marx et al. 1997 . This discrepancy may be related to employment of immunohistochemistry to localize ZR in addition to histological recognition in the later studies. Results of our study, which clearly demonstrated the morphologic appearance of functional ZR cells before 6 years of age, are also in agreement with the reports by Remer and coworkers (Remer et al. 1994) showing earlier detection of urinary adrenal androgens. Results of these morphologic and steroid studies all suggest that the gradual onset of adrenarche occurs earlier than previously postulated, but further investigations are required for clarification.
In the present study, we also demonstrated subtle differences for the age-related progressive development of the ZR between male and female adrenals. Before the onset of ZR development, the total adrenal cortex in female was thicker than that of males within the earlier years of life. Following the onset of puberty, both the total width and the ZR thickness of female adrenals exhibited a faster Figure 5 Analysis of correlation revealed that the morphologically identifiable ZR thickness corresponded well to the thickness of the ZR that was immunopositive for HSD17B5 in both male ((A) rZ0 . 99, P!0 . 01) and female adrenals ((B) rZ0 . 99, P!0 . 01).
development than in male adrenals. In particular, the ratio of ZR thickness of the female adrenal around 16 or 17 years of age in the 13-20-year-old group surpassed 50% of the total cortex suggestive of marked development or remodeling particularly in female adrenals, though there were no significant gender differences in total cortex thickness during this period of development. demonstrated a trend for higher levels of circulating DHEA in girls than in boys from 6 to 10 years of age, but the differences did not reach statistical significance. Therefore, we could not draw a definitive conclusion regarding the sex difference in human adrenals, but female adrenals tended to demonstrate a relatively rapid development of ZR. It awaits further investigations for clarification.
The temporal and spatial intra-adrenal patterns of KI67-positive adrenocortical cells are not only consistent with a putative characteristic of centripetal migration, but also with the hypothesis that the multipotential progenitor cells may exist in the outer ZF or ZG in human adrenal cortex. Lymphocytes and macrophages became discernible in human adrenals near 20 years of age, and the expression of KI67 in the adrenocortical parenchymal cells accordingly declined in these age groups suggesting that the apoptotic ZR cells were possibly removed by phagocytosis, which consequently provide space for the centripetal replacement of ZR cells. Macrophages are detected in the inner zone and belong to the phagocytic compartment characterized by the expression of KiM8 and the adhesion molecules CD68 (GonzaiezHernandez et al. 1994) . They may serve as the scavengers of the apoptotic remnants in the inner cortical layer (Wyllie et al. 1980 , Nathan 1987 , Hayashi et al. 1989 , which may increase in number after 20 years of age.
BCL2 encodes proteins that inhibit apoptosis, thus prolonging the survival of cell populations (Hockenbery et al. 1990) . Results of our present study demonstrated that BCL2 expression was frequently detected in the outer ZF and inversely correlated with its expression in ZR. Therefore, the outer ZF may actively inhibit apoptosis, and the maintenance of the ZR may be achieved by allowing apoptosis or functional conversion of ZR cells at the inner ZF cells or reticularis/fasciculata border. Parker (1991) demonstrated that after ACTH treatment, the compact ZR widens, sometimes sufficiently to encroach on the adjacent ZF. However, it is also important to note that negative expression of BCL2 does not necessarily represent the occurrence of apoptosis as terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay. TUNEL assay could not be performed in our series because of the nature of the materials obtained from autopsy. Therefore, it also awaits further investigations for clarification.
Results of KI67 and BCL2 in developing human adrenals in our present study are consistent with the classical theory of zonation driven by cell migration in human adrenal glands, which was also proposed by Sasano et al. (1995) . In the migration model, each zone is derived from a common pool of progenitor cells located in the peripheral cortex, which then migrate inward and differentiate to populate the inner cortical zones (Sugihara et al. 1977 , Gottschau 1983 , while the ZR is considered a zone of cell senescence followed by their loss from the system following apoptosis (Hoerr 1931 , Nussdorfer 1986 . Results of our present study also demonstrated that proliferative adrenocortical cells invariably exist in outer cortex before 4 years of age followed by abundant expression in ZR during human pubertal ages. The centripetal stream of proliferative parenchymal cells throughout the development may contribute to the enlargement of the ZR. In addition, the balance between KI67 and BCL2 is also considered as the key regulators controlling the development and maturation of ZR in human adrenal glands.
The onset of puberty overlaps with adrenarche and ZR development, but the correlation between these two processes is unclear. Adrenarche has been hypothesized to have an effect on GnRH secretion and the pubertal process because of the increase in adrenal androgen biosynthesis that occurs prior to puberty (Ducharme et al. 1976) . However, DHEA and DHEAS are relatively poor regulators of the androgen receptor and their ability to influence the hypothalamus is not clear. Very recently, Nakamura et al. (2009) have demonstrated that ZR cells express HSD17B5 in human adult adrenals and confirmed that ACTH administration increased serum testosterone levels in female adrenal vein samples, suggesting that HSD17B5 in ZR may play an important role in the production of testosterone in human adrenals. The production of more potent androgens, even in low levels, during the course of adrenarche could provide a new link between adrenarche and puberty. Such androgens would also be more likely to control the process of pubarche, which is considered to occur as a result of adrenarche. In our present study, HSD17B5 was predominantly detected in the ZR of human adrenals around 9 years of age when the pubertal process is considered to be initiated. In addition, some boys with poor adrenal androgen suppression due to undertreated congenital adrenal hyperplasia developed true precocious puberty (Boyar et al. 1973) . Therefore, adrenal HSD17B5 may be involved in pubarche and the onset of puberty by producing more active androgens. Results of our present study do not necessarily establish a definitive correlation between puberty and ZR development, but could provide further insights into the temporal association of the two processes.
